Enliven Therapeutics, Inc.
NASDAQ:ELVNBiotechnology
Healthcare
$46.41 -0.27%
-$0.12 today
- Market cap
- $3.42B
- Beta
- 0.40
- P/E (TTM)
- -28.4
- EPS (TTM)
- -$1.57
52W Low $14.79High $48.53
Volume 0.99M
Average 1.35M
Price history
Enliven Therapeutics, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
+118.19%
Period high
$61.15
Period low
$15.14
Latest
$46.41
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 8-K | Nov 5, 2026 | Nov 5, 2026 | |
| 10-Q | Nov 5, 2026 | Nov 5, 2026 | |
| 4 | Nov 3, 2026 | Nov 3, 2026 | |
| SC 13G/A | Oct 27, 2026 | Oct 27, 2026 | |
| 4 | Oct 21, 2026 | Oct 21, 2026 | |
| 4 | Oct 21, 2026 | Oct 21, 2026 | |
| 4 | Oct 16, 2026 | Oct 16, 2026 | |
| 3 | Oct 16, 2026 | Oct 16, 2026 | |
| 8-K | Oct 14, 2026 | Oct 14, 2026 | |
| 4 | Oct 5, 2026 | Oct 5, 2026 | |
| 4 | Sep 21, 2026 | Sep 21, 2026 | |
| 4 | Sep 21, 2026 | Sep 21, 2026 | |
| 4 | Aug 19, 2026 | Aug 19, 2026 | |
| 4 | Aug 19, 2026 | Aug 19, 2026 | |
| SC 13G/A | Aug 6, 2026 | Aug 6, 2026 |
Competitors
Who does Enliven Therapeutics, Inc. compete with?
Open similar companies to compare their filings and price history.
Questions
Filing questions
Common questions about ELVN's filings, answered from its disclosures.
What is the latest ELVN filing?
The latest filing shown is 8-K dated Nov 5, 2026.
How many recent filings does ELVN have?
Intrinsic Alpha currently shows 20 recent filings for ELVN.
Continue the stock analysis
Jump to another research area for this company.